Gastroenterology
Pancreas Size, Shape Restored With Remission of T2DM
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Pancreas size and shape can be restored with remission of type 2 diabetes, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held virtually from Sept. 21 to 25. Roy Taylor, M.B., Ch.B., M.D., from Newcastle University in the...
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs. John D. Birkmeyer, M.D., from Sound Physicians in Tacoma, Washington, and colleagues conducted a...
Oral Steroids May Raise Risks for Diabetes, HTN, VTE in Children
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Children with current glucocorticoid exposure have increased risks for diabetes mellitus, hypertension, and venous thromboembolism (VTE), according to a study published online Sept. 9 in the American Journal of Epidemiology. Daniel B. Horton, M.D., from the Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, and...
Risk for Cancer Reduced for Patients With Multiple Sclerosis
FRIDAY, Aug. 28, 2020 (HealthDay News) — The risk for cancer is reduced among patients with multiple sclerosis (MS), according to a systematic review and meta-analysis published online Aug. 13 in Autoimmunity Reviews. Mahsa Ghajarzadeh, M.D., M.P.H., from the Tehran University of Medical Sciences in Iran, and colleagues examined the pooled risk for cancer in...
Risk for Gastric cancer Tied to H. Pylori Infection Higher in Blacks, Asians, Hispanics/Latino
Only complete eradication of Helicobacter pylori infection, not treatment alone, will reduce the risk for developing stomach cancer, according to a study recently published in Gastroenterology. Shria Kumar, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues evaluated data for 371,813 patients from the Veterans Health Administration (median age, 62 years;...
Risks of Treatment with Proton Pump Inhibitors
Proton pump inhibitors (PPIs) were initially introduced in the 1980s. Since then PPIs are one of the most common medications prescribed throughout the United States with indications for use in peptic ulcer disease, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and H. pylori infections. The latest research on the long-term risks of PPI treatment has both...
More Medical News
